Zeitpunkt der invasiven Therapie beim NSTEMI: So schnell wie beim STEMI?

A. Jobs; I. Eitel; S. Desch

doi:10.1007/s00059-014-4126-x

Zeitpunkt der invasiven Therapie beim NSTEMI: So schnell wie beim STEMI?

Translated title of the contribution: Timing of invasive treatment in NSTEMI: As fast as in STEMI?

A. Jobs, I. Eitel, S. Desch^*

^*Corresponding author for this work

Department of Internal Medicine II

1 Citation (Scopus)

Abstract

The optimal timing of invasive diagnosis and therapy in patients with non-ST-elevation myocardial infarction (NSTEMI) is still a matter of debate. The European Society of Cardiology recommends invasive diagnosis evaluation and revascularization for practically all patients with NSTEMI within 72 h. High risk and very high risk patients should be evaluated invasively with coronary angiography within 24 h or 2 h, respectively. The risk of the individual patient should be stratified by means of the Global Registry of Acute Coronary Events (GRACE) risk score. The recommendations and guidelines are based on the results of several randomized, controlled trials and are in accordance with other retrospective studies. However, observational studies indicate that in real life many high risk patients are not evaluated invasively by coronary angiography as timely as recommended.

Translated title of the contribution	Timing of invasive treatment in NSTEMI: As fast as in STEMI?
Original language	German
Journal	Herz
Volume	39
Issue number	6
Pages (from-to)	677-684
Number of pages	8
ISSN	0340-9937
DOIs	https://doi.org/10.1007/s00059-014-4126-x
Publication status	Published - 09.10.2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Centers: Cardiological Center Luebeck (UHZL)

DFG Research Classification Scheme

2.22-12 Cardiology, Angiology

Access to Document

10.1007/s00059-014-4126-x

Cite this

@article{7cda08cecd604a5eaf242ed4c5380848,

title = "Zeitpunkt der invasiven Therapie beim NSTEMI: So schnell wie beim STEMI?",

abstract = "The optimal timing of invasive diagnosis and therapy in patients with non-ST-elevation myocardial infarction (NSTEMI) is still a matter of debate. The European Society of Cardiology recommends invasive diagnosis evaluation and revascularization for practically all patients with NSTEMI within 72 h. High risk and very high risk patients should be evaluated invasively with coronary angiography within 24 h or 2 h, respectively. The risk of the individual patient should be stratified by means of the Global Registry of Acute Coronary Events (GRACE) risk score. The recommendations and guidelines are based on the results of several randomized, controlled trials and are in accordance with other retrospective studies. However, observational studies indicate that in real life many high risk patients are not evaluated invasively by coronary angiography as timely as recommended.",

author = "A. Jobs and I. Eitel and S. Desch",

note = "Publisher Copyright: {\textcopyright} 2014, Urban \& Vogel.",

year = "2014",

month = oct,

day = "9",

doi = "10.1007/s00059-014-4126-x",

language = "Deutsch",

volume = "39",

pages = "677--684",

journal = "Herz",

issn = "0340-9937",

publisher = "Springer Medizin",

number = "6",

}

TY - JOUR

T1 - Zeitpunkt der invasiven Therapie beim NSTEMI

T2 - So schnell wie beim STEMI?

AU - Jobs, A.

AU - Eitel, I.

AU - Desch, S.

PY - 2014/10/9

Y1 - 2014/10/9

N2 - The optimal timing of invasive diagnosis and therapy in patients with non-ST-elevation myocardial infarction (NSTEMI) is still a matter of debate. The European Society of Cardiology recommends invasive diagnosis evaluation and revascularization for practically all patients with NSTEMI within 72 h. High risk and very high risk patients should be evaluated invasively with coronary angiography within 24 h or 2 h, respectively. The risk of the individual patient should be stratified by means of the Global Registry of Acute Coronary Events (GRACE) risk score. The recommendations and guidelines are based on the results of several randomized, controlled trials and are in accordance with other retrospective studies. However, observational studies indicate that in real life many high risk patients are not evaluated invasively by coronary angiography as timely as recommended.

AB - The optimal timing of invasive diagnosis and therapy in patients with non-ST-elevation myocardial infarction (NSTEMI) is still a matter of debate. The European Society of Cardiology recommends invasive diagnosis evaluation and revascularization for practically all patients with NSTEMI within 72 h. High risk and very high risk patients should be evaluated invasively with coronary angiography within 24 h or 2 h, respectively. The risk of the individual patient should be stratified by means of the Global Registry of Acute Coronary Events (GRACE) risk score. The recommendations and guidelines are based on the results of several randomized, controlled trials and are in accordance with other retrospective studies. However, observational studies indicate that in real life many high risk patients are not evaluated invasively by coronary angiography as timely as recommended.

UR - https://www.scopus.com/pages/publications/84919843635

U2 - 10.1007/s00059-014-4126-x

DO - 10.1007/s00059-014-4126-x

M3 - Zeitschriftenaufsätze

C2 - 25006076

AN - SCOPUS:84919843635

SN - 0340-9937

VL - 39

SP - 677

EP - 684

JO - Herz

JF - Herz

IS - 6

ER -

Zeitpunkt der invasiven Therapie beim NSTEMI: So schnell wie beim STEMI?

Abstract

UN SDGs

Research Areas and Centers

DFG Research Classification Scheme

Access to Document

Other files and links

Fingerprint

Cite this